Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
Bearish
4
Neutral
3
Bullish
7
Bearish
36
Neutral
3
Bullish
7
Bearish
32
Neutral
0
Bullish
0
Investor Presentation
Q3 FY24
Investor Presentation
Q2 FY24
Investor Presentation
Q1 FY21
Investor Presentation
Q4 FY20

Market Cap
₹ 105 Cr
P/E
—
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
105 Cr
Moderate Risk
—
30.8
—
1.6
19.31
7.75
Sales CAGR
1Y
14.78%
3Y
9.31%
5Y
10.51%
10Y
—
Profit CAGR
1Y
13.89%
3Y
-41.21%
5Y
90.26%
10Y
—
ROE
TTM
-0.57%
3Y
5.49%
5Y
6.70%
10Y
5.84%
ROCE
TTM
1.54%
3Y
9.99%
5Y
12.96%
10Y
14.97%
Performance
UNDER PERFORMER
Valuation
REASONABLE
Growth
SLUGGISH
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Turned 1 L into 2.25 L in last 5 Years